findmyKOL
Clinical trialNCT06527872RecruitingObservational

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

SponsorGlaxoSmithKlineEnrollment300Lupus Nephritis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the OBSErve-LN study is to assess the real-world use and effectiveness of belimumab in routine practice for the treatment of adults with active LN in multiple countries of interest. This study aims to provide the first long-term (up to 5 years) assessment of renal function preservation in belimumab treated participants.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Gsk Investigational Site

    Marseille, France

    Noemie Jourde Chiche
    Recruiting
Italy
  • Gsk Investigational Site

    Rozzano, Milan, Italy

    Francesco Reggiani
    Recruiting
Japan
  • Gsk Investigational Site

    Fukuoka, Japan

    Shingo Nakayamada
    Recruiting
United States
  • Gsk Investigational Site

    Baltimore, Maryland, United States

    Michelle Petri →
    Recruiting
  • Gsk Investigational Site

    Charlotte, North Carolina, United States

    Gordon Lam
    Recruiting
  • Gsk Investigational Site

    Columbus, Ohio, United States

    Isabelle Ayoub
    Recruiting
  • Gsk Investigational Site

    Hixson, Tennessee, United States

    Joseph Huffstutter
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Oct 2024
Primary completion
29 Mar 2029
Completion
29 Mar 2029
Last update posted
2 Jul 2026
Registered enrollment
300
Registry id
NCT06527872
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.